SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-336802
Filing Date
2014-09-09
Accepted
2014-09-09 16:43:07
Documents
4
Period of Report
2014-09-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d786138d8k.htm 8-K 23456
2 EX-4.1 d786138dex41.htm EX-4.1 562082
3 EX-99.1 d786138dex991.htm EX-99.1 8062
4 GRAPHIC g786138g84h73.jpg GRAPHIC 5769
  Complete submission text file 0001193125-14-336802.txt   603013
Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35347 | Film No.: 141093793
SIC: 2834 Pharmaceutical Preparations